Treatment-Resistant Depression (TRD)
If two or more antidepressants haven't worked, you may have treatment-resistant depression. At our Frederick clinic, Dr. Etesam personally leads TRD care using FDA-approved Spravato (esketamine) — an in-office nasal spray that works through a different mechanism than traditional antidepressants.
- FDA-approved for TRD and MDD with acute suicidality
- In-network with Aetna, BCBS, Cigna, United, Medicare
- Manufacturer savings card can reduce copay to as low as $10/session
- Prior authorization handled in-house at no cost to you